Costo-efectividad de los medios de contraste ISO e hiposmolares en pacientes con riesgo elevado

Cost-Effectiveness of high- and low-osmolality contrast media in patients with high risk of contrast induced nephropathy

Liliana Chicaíza, Mario García and Oscar Gamboa

Econógrafos, Escuela de Economía from Universidad Nacional de Colombia, FCE, CID

Abstract: Contrast media induced nephropathy is a common cause of kidney failure in hospitalized patients. It has been suggested that high-osmolality contrast media caused less nephropathies than low-osmolality ones. The cost-effectiveness of High- (Iodixanol) and Low- osmolality (Iohexol, Iopamidol and others) contrast media are compared by means of a decision tree. The analysis showed that Iopamidol and Iodixanol strategies dominated all the others. The incremental cost-effectiveness ratio of Iodixanol compared to Iopamidol is $31.637.306 per adicional avoided nephropathy. Iodixanol strategy is cost-effective for a budget per patient higher than $980.000, or 50 ml vial cost lower than $57.000, or willingness to pay per nephropathy avoided higher than $32.000.000.

Keywords: Cost-effectiveness; Health; Health care; Kidney failure; Contrast media (search for similar items in EconPapers)
JEL-codes: D61 I11 (search for similar items in EconPapers)
Pages: 15
Date: 2011
References: Add references at CitEc
Citations:

Published in Econografos

Downloads: (external link)
https://fce.unal.edu.co/centro-editorial/documento ... documento-EACP-4.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:col:000176:022902

Access Statistics for this paper

More papers in Econógrafos, Escuela de Economía from Universidad Nacional de Colombia, FCE, CID Contact information at EDIRC.
Bibliographic data for series maintained by Facultad de Ciencias Económicas Unal ().